No Data
No Data
UBS Initiates ONO PHARMACEUTICAL CO(OPHLF.US) With Sell Rating, Announces Target Price $13
Jefferies Initiates ONO PHARMACEUTICAL CO(OPHLF.US) With Hold Rating, Announces Target Price $15.69
ONO PHARMACEUTICAL CO To Go Ex-Dividend On September 27th, 2024 With 0.352 USD Dividend Per Share
Express News | Equillium Inc - Delivery of Interim Data Review to Ono Pharmaceutical Co. Ltd. (Ono) Expected During Q3 Will Trigger Ono's Option Exercise Period
Earnings Call Summary | ONO PHARMACEUTICAL CO(OPHLF.US) Q1 2024 Earnings Conference
Shareholder Alert: Ademi LLP Investigates Whether Deciphera Pharmaceuticals, Inc. Has Obtained a Fair Price in Its Transaction With ONO Pharmaceutical Co.
No Data
No Data